Risk of erythrocytosis in transgender individuals undergoing testosterone therapy: a systematic review.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 205, doi. 10.23736/S2724-6507.24.04171-X
- By:
- Publication type:
- Article
Works matching IS 27246507 AND DT 2024 AND VI 49 AND IP 2
Results: 14
1
2
Quality of outcome reporting for clinical trails on medullary thyroid cancer registered on ClinicalTrials.gov.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 230, doi. 10.23736/S2724-6507.23.04034-4
- By:
- Publication type:
- Article
3
A comparison of intensive insulin therapy and dipeptidyl peptidase-4 inhibitor plus metformin combination in newly diagnosed type 2 diabetes mellitus.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 228, doi. 10.23736/S2724-6507.23.03928-3
- By:
- Publication type:
- Article
4
Improvement of type 2 diabetes in a bipolar patient after initiation of atypical antipsychotic therapy.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 226, doi. 10.23736/S2724-6507.22.03900-8
- By:
- Publication type:
- Article
5
Autosomal dominant pseudohypoparathyroidism type 1b due to STX16 deletion: a case presentation and literature review.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 217, doi. 10.23736/S2724-6507.20.03233-2
- By:
- Publication type:
- Article
6
Pharmacological treatment of non-responders following bariatric surgery.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 196, doi. 10.23736/S2724-6507.21.03311-3
- By:
- Publication type:
- Article
7
Semaglutide and obesity: beyond the nutritional and lifestyle intervention?
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 182, doi. 10.23736/S2724-6507.23.04103-9
- By:
- Publication type:
- Article
8
Clinicopathological significance of epidermal growth factor receptor expression in papillary thyroid carcinoma: a meta-analysis.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 175, doi. 10.23736/S2724-6507.20.03388-X
- By:
- Publication type:
- Article
9
Recent advances and future challenges in the diagnosis of neuroendocrine neoplasms.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 158, doi. 10.23736/S2724-6507.23.04140-4
- By:
- Publication type:
- Article
10
The mTOR-inhibitor everolimus reduces hypervolemia in patients with primary aldosteronism.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 150, doi. 10.23736/S2724-6507.21.03382-0
- By:
- Publication type:
- Article
11
Safety and effects of calcifediol 0.266 milligrams soft capsules monthly and cholecalciferol 25000 international units monthly in osteoporotic women undergoing therapy with alendronate: a cross-sectional study.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 141, doi. 10.23736/S2724-6507.24.03920-4
- By:
- Publication type:
- Article
12
Effects of magnesium supplementation on post-thyroidectomy hypocalcemia: a prospective single-center study.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 132, doi. 10.23736/S2724-6507.21.03526-0
- By:
- Publication type:
- Article
13
Combining TSH measurement with TIRADS assessment to further improve the detection of thyroid cancers.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 125, doi. 10.23736/S2724-6507.24.04207-6
- By:
- Publication type:
- Article
14
Highlights of the April-June 2024 issue.
- Published in:
- Minerva Endocrinology, 2024, v. 49, n. 2, p. 123, doi. 10.23736/S2724-6507.24.04238-6
- By:
- Publication type:
- Article